Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H+-ATPase as an emerging target

Author： Kartner Norbert   Manolson Morris F  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.5, 2014-05, pp. : 505-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective Inhibition of Osteoclast Vacuolar H+-ATPase

By  

Current Pharmaceutical Design, Vol. 8, Iss. 23, 2002-10 ,pp. : 2033-2048

Bentham Science Publishers

Access to resources Recommend Favorite

Selective inhibitors of vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity

By Farina C.   Gagliardi S.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 157-168

Informa Healthcare

Access to resources Recommend Favorite

Novel Marine and Microbial Natural Product Inhibitors of Vacuolar ATPase

By  

Current Medicinal Chemistry, Vol. 10, Iss. 9, 2003-05 ,pp. : 787-796

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1147-1151

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H4 Receptor: A Novel Target for Inflammation Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-02 ,pp. : 143-158

Bentham Science Publishers

Access to resources Recommend Favorite